CFO Mark Austin departs; separation agreement provides $138K severance and COBRA subsidy

Perspective Therapeutics, Inc.

Mark Austin ceased as executive officer and co-principal financial officer on Aug 16, 2024.
Separation agreement finalized Aug 26, 2024; Austin remains strategic advisor through Aug 30, 2024.
Severance includes $138,360.75 (6 months base salary) and $7,686.54 for COBRA coverage.
Payments conditional on signing release and compliance with separation terms.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark Austin

co-principal financial officer and principal accounting officer

CATX · Perspective Therapeutics, Inc.

Effective: 2024-08-16
Filed: August 30, 2024, 7:59 PM ET

Mark Austin ceased serving as an executive officer of the Company and as the Company's “co-principal financial officer” and “principal accounting officer” on August 16, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Austin departed as co-principal financial officer and principal accounting officer at Perspective Therapeutics, Inc..

Action: ceased serving as executive officer and co-principal financial officer
Role: co-principal financial officer and principal accounting officer

Exact text from the filing

Mark Austin ceased serving as an executive officer of the Company and as the Company's “co-principal financial officer” and “principal accounting officer” on August 16, 2024.

View on SEC.gov

Perspective Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-102338

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.